WO2014058973A1 - Systems & methods for combined femto-phaco cataract surgery - Google Patents
Systems & methods for combined femto-phaco cataract surgery Download PDFInfo
- Publication number
- WO2014058973A1 WO2014058973A1 PCT/US2013/064051 US2013064051W WO2014058973A1 WO 2014058973 A1 WO2014058973 A1 WO 2014058973A1 US 2013064051 W US2013064051 W US 2013064051W WO 2014058973 A1 WO2014058973 A1 WO 2014058973A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- phacoemulsification
- subsystem
- procedures
- menu
- select
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/008—Methods or devices for eye surgery using laser
- A61F9/00825—Methods or devices for eye surgery using laser for photodisruption
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/00736—Instruments for removal of intra-ocular material or intra-ocular injection, e.g. cataract instruments
- A61F9/00745—Instruments for removal of intra-ocular material or intra-ocular injection, e.g. cataract instruments using mechanical vibrations, e.g. ultrasonic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/008—Methods or devices for eye surgery using laser
- A61F2009/00861—Methods or devices for eye surgery using laser adapted for treatment at a particular location
- A61F2009/0087—Lens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/008—Methods or devices for eye surgery using laser
- A61F2009/00885—Methods or devices for eye surgery using laser for treating a particular disease
- A61F2009/00887—Cataract
Definitions
- the field of the invention is cataract surgery.
- phacoemulsification which is colloquially known as "phaco”.
- the internal lens of an eye is emulsified with an ultrasonic handpiece, and the detritus is aspirated from the eye. Aspirated fluids are replaced with irrigation of balanced salt solution.
- an intraocular lens implant IOL
- IOL intraocular lens implant
- the phaco probe is an ultrasonic handpiece with a titanium or steel needle.
- the tip of the needle vibrates at ultrasonic frequency to sculpt and emulsify the cataract, while the pump aspirates particles through the tip.
- a second fine steel instrument called a "chopper" is used from a side port to help with chopping the nucleus into smaller pieces.
- the cataract is usually broken into two or four pieces and each piece is emulsified and aspirated out with suction.
- the nucleus emulsification makes it easier to aspirate the particles. After removing all hard central lens nucleus with phacoemulsification, the softer outer lens cortex is removed with suction only.
- Phacoemulsification surgery involves the use of a machine with microprocessor- controlled fluid dynamics. Emulsification power applied through the probe, vacuum strength of the aspirator, and other operating parameters of the phaco device are controlled through software. Examples of graphic user interfaces of popular phacoemulsification software are depicted in prior art Figures 1 and 2.
- phacoemulsification is performed by two entirely separate machines, requiring translocation and re-setup of the patient. This increases the time required for the procedure, and can cause undue stress on the patient.
- the inventive subject matter provides apparatus, systems and methods in which devices to perform femtolaser ablation and phacoemulsification are physically and/or operationally combined.
- At least one subsystem of the femtolaser ablation functionality is housed in a common housing with at least one subsystem of the phacoemulsification functionality.
- a display screen displays both a first graphical user interface for the femtolaser ablation functionality and a second graphical user interface for the
- software includes instructions disposed on a non-transitory computer-readable medium that are common to operation of both the femtolaser ablation functionality and the phacoemulsification functionality.
- a non-transitory computer-readable memory provides data that can be used to operate each of the femtolaser ablation functionality and the phacoemulsification functionality.
- Fig. 1 is a screen shot of a prior art graphical user interface for a phacoemulsification device.
- Fig. 2 is a screen shot of an alternative prior art graphical user interface for a phacoemulsification device.
- FIG. 3 is a prior art representation of the phacoemulsification device of Figures 1 and 2.
- FIG. 4 is a prior art representation of a display of the phacoemulsification device of Figures 1 and 2, showing an eye during phacoemulsification.
- FIG. 5 is a prior art representation of a display of the phacoemulsification device of Figures 1 and 2, showing an eye during aspiration.
- Fig. 6 is a prior art screen shot of a prior art graphical user interface for a femtolaser ablation device.
- Fig. 7 is a screen shot of another prior art graphical user interface of the femtolaser ablation device of Figure 3.
- FIG. 8 is a prior art representation medical personnel using the femtolaser ablation device of Figures 6 and 7.
- FIG. 9 is a prior art representation medical personnel using the femtolaser ablation device of Figures 6 and 7.
- Fig. 10 is another prior art representation of a femtolaser ablation device.
- Fig. 11 is a schematic of a graphical user interface of software configured to control both a femtolaser ablation device and a phacoemulsification device.
- Fig. 12 is a schematic of the graphical user interface of Figure 11, showing a menu of procedures that can be selected for the femtolaser ablation device.
- Fig. 13 is a schematic of the graphical user interface of Figure 11, showing a menu of procedures that can be selected for the phacoemulsification device.
- Fig. 14 is a schematic of the graphical user interface of Figure 11, concurrently showing menus of procedures that can be selected for the femtolaser ablation device and the phacoemulsification device
- Fig. 15 is a schematic of a graphical user interface concurrently showing menus of procedures that can be selected for a device that combines femtolaser ablation functionality and phacoemulsification functionality.
- Fig. 16 is a schematic of a device that combines femtolaser ablation functionality and phacoemulsification functionality, using a common GUI control platform.
- Fig. 17 is a schematic of a device that utilizes a common GUI control platform to control physically separate femtolaser ablation and phacoemulsification devices.
- inventive subject matter provides example embodiments of the inventive subject matter. Although each embodiment represents a single combination of inventive elements, the inventive subject matter is considered to include all possible combinations of the disclosed elements. Thus if one embodiment comprises elements A, B, and C, and a second embodiment comprises elements B and D, then the inventive subject matter is also considered to include other remaining combinations of A, B, C, or D, even if not explicitly disclosed.
- a single GUI and/or software can combine control of ophthalmic phacoemulsification and femtolaser functionalities for cataract removal. These can be combined in many diverse ways for surgical use on at least one of a computer touch screen, a set of dedicated buttons, a foot pedal, and a voice interface.
- Fig. 11 is a schematic of a graphical user interface of software configured to control both a femtolaser ablation device and a phacoemulsification device.
- the platform can be local to one or more of the devices, and can alternatively or additionally be at least partially disposed on one or more distal servers (e.g., cloud, PaaS, IaaS, SaaS, etc.).
- distal servers e.g., cloud, PaaS, IaaS, SaaS, etc.
- Coupled to is intended to include both direct coupling (in which two elements that are coupled to each other contact each other) and indirect coupling (in which at least one additional element is located between the two elements). Therefore, the terms “coupled to” and “coupled with” are used synonymously.
- the terms “coupled to” and “coupled with” are also use euphemistically to mean
- any language directed to a computer or software platform should be read to include any suitable combination of computing devices, including servers, interfaces, systems, databases, agents, peers, engines, controllers, or other types of computing devices operating individually or collectively.
- the computing devices comprise a processor configured to execute software instructions stored on a tangible, non- transitory computer readable storage medium (e.g., hard drive, solid state drive, RAM, flash, ROM, etc.).
- the software instructions preferably configure the computing device to provide the roles, responsibilities, or other functionality as discussed below with respect to the disclosed apparatus.
- the various servers, systems, databases, or interfaces exchange data using standardized protocols or algorithms, possibly based on HTTP, HTTPS, AES, public-private key exchanges, web service APIs, known financial transaction protocols, or other electronic information exchanging methods.
- Data exchanges preferably are conducted over a packet-switched network, the Internet, LAN, WAN, VPN, or other type of packet switched network.
- FIG. 12 is a schematic of the graphical user interface of Figure 1 1 , showing a menu of procedures that can be selected for the femtolaser ablation device. These are exemplary procedures only, and contemplated femtolaser GUI interfaces may list other or additional procedures.
- Figures 12 - 15 are merely schematics, and commercial embodiments of the interfaces would be much more detailed and user friendly, such as along the lines of that shown in Figures 1 or 2.
- Fig. 13 is a schematic of the graphical user interface of Figure 1 1 , showing a menu of procedures that can be selected for the phacoemulsification device.
- Fig. 14 is a schematic of the graphical user interface of Figure 1 1 , concurrently showing menus of procedures that can be selected for separate femtolaser ablation and phacoemulsification devices.
- Fig. 15 is a schematic of a graphical user interface concurrently showing menus of procedures that can be selected for a device that combines femtolaser ablation functionality and phacoemulsification functionality.
- This interface differs from that shown in Figure 14 because the listing of functionalities is customized in some manner, for example by including custom functionalities not programmed into off-the-shelf devices, and/or by hiding functionalities that might otherwise be available.
- Such customization of main menu and/or submenu procedures for phaco and femto could be arranged by the manufacturer and/or or surgeon in an order that is thought to best fit the process of cataract removal and soft lens insertion for a particular practitioner or office.
- FIG. 16 is a schematic of a device that combines femtolaser ablation functionality and phacoemulsification functionality, using a common GUI control platform.
- Fig. 17 is a schematic of a device that utilizes a common GUI control platform to control physically separate femtolaser ablation and phacoemulsification devices.
- Each of the interfaces of Figures 12-15 could be used with each of the embodiments shown in Figures 16 and 17.
Landscapes
- Health & Medical Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Veterinary Medicine (AREA)
- Surgery (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- User Interface Of Digital Computer (AREA)
Abstract
Devices to perform femtolaser ablation and phacoemulsification are physically and/or operationally combined. In some embodiments the femtolaser ablation and phacoemulsifica-tion are housed together, and in other embodiments they are housed separately, but operated through a common display screen. At least some software can be shared by the femtolaser ablation and phacoemulsification functionalities. A non-transitory computer-readable memory can provide data that can be used to operate each of at least one femtolaser ablation functionality and at least one phacoemulsification functionality.
Description
SYSTEMS & METHODS FOR COMBINED FEMTO-PHACO
CATARACT SURGERY
[0001] This application claims priority to US Patent Application No. 13/648,196, filed October 9, 2012, which claims priority to US Provisional Application No. 61/543,930, filed October 6, 2011 which is incorporated herein by reference in its entirety.
Field of the Invention
[0002] The field of the invention is cataract surgery. Background
[0003] Modern cataract surgery is commonly performed using phacoemulsification, which is colloquially known as "phaco". In that process the internal lens of an eye is emulsified with an ultrasonic handpiece, and the detritus is aspirated from the eye. Aspirated fluids are replaced with irrigation of balanced salt solution. As with other cataract extraction procedures, an intraocular lens implant (IOL), is placed into the remaining lens capsule. See
[0004] The referenced Wikipedia article, as well as all other extrinsic materials discussed herein are incorporated by reference in their entirety. Where a definition or use of a term in an incorporated reference is inconsistent or contrary to the definition of that term provided herein, the definition of that term provided herein applies and the definition of that term in the reference does not apply.
[0005] The phaco probe is an ultrasonic handpiece with a titanium or steel needle. The tip of the needle vibrates at ultrasonic frequency to sculpt and emulsify the cataract, while the pump aspirates particles through the tip. In some techniques, a second fine steel instrument called a "chopper" is used from a side port to help with chopping the nucleus into smaller pieces. The cataract is usually broken into two or four pieces and each piece is emulsified and aspirated out with suction. The nucleus emulsification makes it easier to aspirate the particles. After removing all hard central lens nucleus with phacoemulsification, the softer outer lens cortex is removed with suction only.
[0006] Phacoemulsification surgery involves the use of a machine with microprocessor- controlled fluid dynamics. Emulsification power applied through the probe, vacuum strength
of the aspirator, and other operating parameters of the phaco device are controlled through software. Examples of graphic user interfaces of popular phacoemulsification software are depicted in prior art Figures 1 and 2.
[0007] Before phacoemulsification can be performed, one or more incisions are typically made in the eye to allow the introduction of surgical instruments. The surgeon then removes the anterior face of the capsule that contains the lens inside the eye. During that part of the procedure, difficulties sometimes arise during the incision portion of the procedure, potentially causing damage to the eye.
[0008] It is known to use femtosecond laser pulses to make incisions into the eye, and recently devices are available for remediating cataracts using femtolaser ablation. One device currently in the marketplace for accomplishing that is Technolas Perfect Vision's™ VICTUS™ Femtosecond Laser Platform. See
http://www.technolaspv.com/dasat/index.php?cid=100858. Femtolaser ablation of cataracts can remove even fairly large cataracts quite quickly, but (1) some portions of cataract can remain, requiring phacoemulsification, and (2) detritus must still be removed using irrigation and aspiration.
[0009] Currently, cataract remediation using femtolaser ablation followed by
phacoemulsification is performed by two entirely separate machines, requiring translocation and re-setup of the patient. This increases the time required for the procedure, and can cause undue stress on the patient.
[0010] Thus, there is a need to combine femtolaser ablation and phacoemulsification either in the same device, or at least in separate devices that are operated using a combined software platform.
Summary of The Invention
[0011] The inventive subject matter provides apparatus, systems and methods in which devices to perform femtolaser ablation and phacoemulsification are physically and/or operationally combined.
[0012] In one aspect, at least one subsystem of the femtolaser ablation functionality is housed in a common housing with at least one subsystem of the phacoemulsification functionality.
[0013] In another aspect, a display screen displays both a first graphical user interface for the femtolaser ablation functionality and a second graphical user interface for the
phacoemulsification functionality.
[0014] In another aspect, software includes instructions disposed on a non-transitory computer-readable medium that are common to operation of both the femtolaser ablation functionality and the phacoemulsification functionality.
[0015] In another aspect a non-transitory computer-readable memory provides data that can be used to operate each of the femtolaser ablation functionality and the phacoemulsification functionality.
[0016] Various objects, features, aspects and advantages of the inventive subject matter will become more apparent from the following detailed description of preferred embodiments, along with the accompanying drawing figures in which like numerals represent like components.
Brief Description of The Drawing
[0017] Fig. 1 is a screen shot of a prior art graphical user interface for a phacoemulsification device.
[0018] Fig. 2 is a screen shot of an alternative prior art graphical user interface for a phacoemulsification device.
[0019] Fig. 3 is a prior art representation of the phacoemulsification device of Figures 1 and 2.
[0020] Fig. 4 is a prior art representation of a display of the phacoemulsification device of Figures 1 and 2, showing an eye during phacoemulsification.
[0021] Fig. 5 is a prior art representation of a display of the phacoemulsification device of Figures 1 and 2, showing an eye during aspiration.
[0022] Fig. 6 is a prior art screen shot of a prior art graphical user interface for a femtolaser ablation device.
[0023] Fig. 7 is a screen shot of another prior art graphical user interface of the femtolaser ablation device of Figure 3.
[0024] Fig. 8 is a prior art representation medical personnel using the femtolaser ablation device of Figures 6 and 7.
[0025] Fig. 9 is a prior art representation medical personnel using the femtolaser ablation device of Figures 6 and 7.
[0026] Fig. 10 is another prior art representation of a femtolaser ablation device.
[0027] Fig. 11 is a schematic of a graphical user interface of software configured to control both a femtolaser ablation device and a phacoemulsification device.
[0028] Fig. 12 is a schematic of the graphical user interface of Figure 11, showing a menu of procedures that can be selected for the femtolaser ablation device.
[0029] Fig. 13 is a schematic of the graphical user interface of Figure 11, showing a menu of procedures that can be selected for the phacoemulsification device.
[0030] Fig. 14 is a schematic of the graphical user interface of Figure 11, concurrently showing menus of procedures that can be selected for the femtolaser ablation device and the phacoemulsification device
[0031] Fig. 15 is a schematic of a graphical user interface concurrently showing menus of procedures that can be selected for a device that combines femtolaser ablation functionality and phacoemulsification functionality.
[0032] Fig. 16 is a schematic of a device that combines femtolaser ablation functionality and phacoemulsification functionality, using a common GUI control platform.
[0033] Fig. 17 is a schematic of a device that utilizes a common GUI control platform to control physically separate femtolaser ablation and phacoemulsification devices.
Detailed Description
[0034] The following discussion provides example embodiments of the inventive subject matter. Although each embodiment represents a single combination of inventive elements, the inventive subject matter is considered to include all possible combinations of the
disclosed elements. Thus if one embodiment comprises elements A, B, and C, and a second embodiment comprises elements B and D, then the inventive subject matter is also considered to include other remaining combinations of A, B, C, or D, even if not explicitly disclosed.
[0035] As used herein, and unless the context dictates the contrary, all ranges set forth herein should be interpreted as being inclusive of their endpoints, and open-ended ranges should be interpreted to include commercially practical values. Similarly, all lists of values should be considered as inclusive of intermediate values unless the context indicates the contrary.
[0036] As seen in Figures 11-15, it is contemplated that a single GUI and/or software can combine control of ophthalmic phacoemulsification and femtolaser functionalities for cataract removal. These can be combined in many diverse ways for surgical use on at least one of a computer touch screen, a set of dedicated buttons, a foot pedal, and a voice interface.
[0037] Fig. 11 is a schematic of a graphical user interface of software configured to control both a femtolaser ablation device and a phacoemulsification device. The platform can be local to one or more of the devices, and can alternatively or additionally be at least partially disposed on one or more distal servers (e.g., cloud, PaaS, IaaS, SaaS, etc.). Each of the devices shown in the figures should be interpreted as including electronics and software needed to operate the device, and the software should be interpreted as capable of reading and utilizing data from one or more databases.
[0038] Devices shown in the figures with connecting lines should be interpreted as being at least functionally coupled to one another, and in some embodiments physically coupled to one another. Thus, a display device shown with a connecting line to a femtolaser ablation device should be interpreted as being at least electronically coupled to one another. As used herein, and unless the context dictates otherwise, the term "coupled to" is intended to include both direct coupling (in which two elements that are coupled to each other contact each other) and indirect coupling (in which at least one additional element is located between the two elements). Therefore, the terms "coupled to" and "coupled with" are used synonymously. The terms "coupled to" and "coupled with" are also use euphemistically to mean
"communicatively coupled with" in a networking sense where at least two networked elements are able to communicate with each other over a network possibly via one or more intermediary devices.
[0039] It should be noted that any language directed to a computer or software platform should be read to include any suitable combination of computing devices, including servers, interfaces, systems, databases, agents, peers, engines, controllers, or other types of computing devices operating individually or collectively. One should appreciate the computing devices comprise a processor configured to execute software instructions stored on a tangible, non- transitory computer readable storage medium (e.g., hard drive, solid state drive, RAM, flash, ROM, etc.). The software instructions preferably configure the computing device to provide the roles, responsibilities, or other functionality as discussed below with respect to the disclosed apparatus. In especially preferred embodiments, the various servers, systems, databases, or interfaces exchange data using standardized protocols or algorithms, possibly based on HTTP, HTTPS, AES, public-private key exchanges, web service APIs, known financial transaction protocols, or other electronic information exchanging methods. Data exchanges preferably are conducted over a packet-switched network, the Internet, LAN, WAN, VPN, or other type of packet switched network.
[0040] Fig. 12 is a schematic of the graphical user interface of Figure 1 1 , showing a menu of procedures that can be selected for the femtolaser ablation device. These are exemplary procedures only, and contemplated femtolaser GUI interfaces may list other or additional procedures. One should also appreciate that each of Figures 12 - 15 are merely schematics, and commercial embodiments of the interfaces would be much more detailed and user friendly, such as along the lines of that shown in Figures 1 or 2.
[0041] Fig. 13 is a schematic of the graphical user interface of Figure 1 1 , showing a menu of procedures that can be selected for the phacoemulsification device.
[0042] Fig. 14 is a schematic of the graphical user interface of Figure 1 1 , concurrently showing menus of procedures that can be selected for separate femtolaser ablation and phacoemulsification devices.
[0043] Fig. 15 is a schematic of a graphical user interface concurrently showing menus of procedures that can be selected for a device that combines femtolaser ablation functionality and phacoemulsification functionality. This interface differs from that shown in Figure 14 because the listing of functionalities is customized in some manner, for example by including custom functionalities not programmed into off-the-shelf devices, and/or by hiding functionalities that might otherwise be available. Such customization of main menu and/or
submenu procedures for phaco and femto could be arranged by the manufacturer and/or or surgeon in an order that is thought to best fit the process of cataract removal and soft lens insertion for a particular practitioner or office.
[0044] Fig. 16 is a schematic of a device that combines femtolaser ablation functionality and phacoemulsification functionality, using a common GUI control platform. Fig. 17 is a schematic of a device that utilizes a common GUI control platform to control physically separate femtolaser ablation and phacoemulsification devices. Each of the interfaces of Figures 12-15 could be used with each of the embodiments shown in Figures 16 and 17.
[0045] It should be apparent to those skilled in the art that many more modifications besides those already described are possible without departing from the inventive concepts herein. The inventive subject matter, therefore, is not to be restricted except in the scope of the appended claims. Moreover, in interpreting both the specification and the claims, all terms should be interpreted in the broadest possible manner consistent with the context. In particular, the terms "comprises" and "comprising" should be interpreted as referring to elements, components, or steps in a non-exclusive manner, indicating that the referenced elements, components, or steps may be present, or utilized, or combined with other elements, components, or steps that are not expressly referenced. Where the specification claims refers to at least one of something selected from the group consisting of A, B, C .... and N, the text should be interpreted as requiring only one element from the group, not A plus N, or B plus N, etc.
Claims
1. A system for removing a cataract from an eye, comprising:
a first set of controls configured to operate a pulsed laser subsystem to cut a tissue structure of the eye with a laser beam; and
a second set of controls configured to operate a phacoemulsification subsystem that uses ultrasonic waves to emulsify at least a portion of the cataract.
2. The system of claim 1, wherein at least a portion of the pulsed laser subsystem is housed in a common housing with at least a portion of the phacoemulsification subsystem.
3. The system of claim 1, further comprising a display screen that displays a first graphical user interface for the pulsed laser subsystem and a second graphical user interface for the phacoemulsification subsystem.
4. The system of claim 1, further comprising instructions disposed on a non-transitory computer-readable medium common to operation of both the pulsed laser subsystem and the phacoemulsification functionality.
5. The system of claim 1, further comprising a non-transitory computer-readable memory that provides data that can be used to operate each of the pulsed laser subsystem and the phacoemulsification subsystem.
6. The system of claim 1, further comprising a control panel that includes both (a) at least a portion of the first set of controls and (b) at least a portion of the second set of controls.
7. The system of claim 1, wherein the pulsed laser subsystem includes a laser configured to produce femtosecond laser pulses.
8. The system of claim 1, wherein the pulsed laser subsystem further comprises a menu from which a user can select among procedures that include a scan.
9. The system of claim 1, wherein the pulsed laser subsystem further comprises a menu from which a user can select among procedures that include a primary incision and a secondary incision.
10. The system of claim 1, wherein the pulsed laser subsystem further comprises a menu from which a user can select among procedures that include limbus centration, capsule range, and laser capsulotomy procedure.
11. The system of claim 1 , wherein the phacoemulsification subsystem further comprises a menu from which a user can select among procedures that include irrigation and vacuum.
12. The system of claim 1, wherein the phacoemulsification subsystem further comprises a menu from which a user can select among procedures that include diatermy and coagulation.
13. The system of claim 1, wherein the phacoemulsification subsystem further comprises a menu from which a user can select among procedures that include Sculpt, Flop and Chop, and laser capsulotomy.
14. The system of claim 1, wherein the phacoemulsification subsystem further comprises a menu from which a user can select among procedures that include vit and visco.
15. The system of claim 1, wherein the phacoemulsification subsystem further comprises a menu from which a user can select among procedures that include flow and IV pole.
16. The system of claim 1, further comprising a menu from which a user can select among laser-specific procedures and phacoemulsification-specific procedures.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/648,196 US8986290B2 (en) | 2011-10-06 | 2012-10-09 | Systems and methods for combined femto-phaco cataract surgery |
US13/648,196 | 2012-10-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2014058973A1 true WO2014058973A1 (en) | 2014-04-17 |
Family
ID=50478112
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2013/064051 WO2014058973A1 (en) | 2012-10-09 | 2013-10-09 | Systems & methods for combined femto-phaco cataract surgery |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2014058973A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP4218695A1 (en) * | 2020-01-03 | 2023-08-02 | Lensar, Inc. | Integrated systems for predetermined combination laser-phacoemulsification therapies |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006073400A1 (en) * | 2005-01-05 | 2006-07-13 | Advanced Medical Optics, Inc. | Phacoemulsification system utilizing graphical user interfaces for adjusting pulse parameters |
US7137980B2 (en) * | 1998-10-23 | 2006-11-21 | Sherwood Services Ag | Method and system for controlling output of RF medical generator |
US20080281303A1 (en) * | 2007-03-13 | 2008-11-13 | William Culbertson | Method and apparatus for creating ocular surgical and relaxing incisions |
WO2009023809A1 (en) * | 2007-08-15 | 2009-02-19 | Advanced Medical Optics, Inc. | Systems and methods for managing and distributing user profiles for surgical systems |
US20100156646A1 (en) * | 2008-12-19 | 2010-06-24 | Cull Laurence J | System to identify viscosity of aspirated material during ophthalmic surgery |
WO2011147570A1 (en) * | 2010-05-27 | 2011-12-01 | Carl Zeiss Meditec Ag | Device and method for cataract surgery |
-
2013
- 2013-10-09 WO PCT/US2013/064051 patent/WO2014058973A1/en active Application Filing
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7137980B2 (en) * | 1998-10-23 | 2006-11-21 | Sherwood Services Ag | Method and system for controlling output of RF medical generator |
WO2006073400A1 (en) * | 2005-01-05 | 2006-07-13 | Advanced Medical Optics, Inc. | Phacoemulsification system utilizing graphical user interfaces for adjusting pulse parameters |
US20080281303A1 (en) * | 2007-03-13 | 2008-11-13 | William Culbertson | Method and apparatus for creating ocular surgical and relaxing incisions |
WO2009023809A1 (en) * | 2007-08-15 | 2009-02-19 | Advanced Medical Optics, Inc. | Systems and methods for managing and distributing user profiles for surgical systems |
US20100156646A1 (en) * | 2008-12-19 | 2010-06-24 | Cull Laurence J | System to identify viscosity of aspirated material during ophthalmic surgery |
WO2011147570A1 (en) * | 2010-05-27 | 2011-12-01 | Carl Zeiss Meditec Ag | Device and method for cataract surgery |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP4218695A1 (en) * | 2020-01-03 | 2023-08-02 | Lensar, Inc. | Integrated systems for predetermined combination laser-phacoemulsification therapies |
EP4218694A1 (en) * | 2020-01-03 | 2023-08-02 | Lensar, Inc. | Methods and systems for combined sonic and laser applications for the eye |
EP4084752A4 (en) * | 2020-01-03 | 2024-01-10 | Lensar Inc | Integrated systems for predetermined combination laser-phacoemulsification therapies |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11540943B2 (en) | Systems and methods for combined femto-phaco cataract surgery | |
US20210298954A1 (en) | Coordinated control of a water jet flow and an aspiration flow | |
US10744035B2 (en) | Methods for robotic assisted cataract surgery | |
EP3212138B1 (en) | Vitrectomy probe with an optical fiber scanner | |
JP6401276B2 (en) | Apparatus, system and method for vacuum control of chip during aspiration | |
JP2018537214A (en) | Single-port hybrid gauge surgical device and method | |
US20150297407A1 (en) | Cataract removal device and integrated tip | |
DK2766063T3 (en) | RETINAL LASER SURGERY | |
US20180214308A1 (en) | Posterior capsulotomy using laser techniques | |
WO2017139371A1 (en) | Tip detection apparatus and method for medical device | |
US10052227B2 (en) | Cataract removal device and integrated tip | |
KR20140061541A (en) | Tissue removal devices, systems and methods | |
WO2014039093A1 (en) | System for performing micro-static tissue removal | |
US20230040764A1 (en) | Managing phacoemulsification user defined protocols | |
JP2017504384A (en) | Tissue-sensing vitrectomy surgical system and method. | |
EP2967987B1 (en) | Fluidics adjustment techniques for use in a surgical procedure | |
Gurnani et al. | Phacoemulsification | |
EP3134020B1 (en) | Medical device data filtering for real time display | |
WO2018138592A1 (en) | Vacuum control for a vitrectomy probe | |
US20220313489A1 (en) | Systems and method for smart phaco in surgical systems | |
US20230248571A1 (en) | Systems & Methods for Combined Femto-Phaco Cataract Surgery | |
US20140316392A1 (en) | Method, Apparatus, and a System for a Water Jet | |
WO2014058973A1 (en) | Systems & methods for combined femto-phaco cataract surgery | |
WO2023017333A1 (en) | Automatic control of phacoemulsification needle trajectory | |
US20220395395A1 (en) | Irrigation in a phacoemulsification system |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 13845702 Country of ref document: EP Kind code of ref document: A1 |
|
DPE1 | Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101) | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 13845702 Country of ref document: EP Kind code of ref document: A1 |